1: Xi ZX, Gardner EL. Pharmacological actions of NGB 2904, a selective dopamine D3 receptor antagonist, in animal models of drug addiction. CNS Drug Rev. 2007 Summer;13(2):240-59. doi: 10.1111/j.1527-3458.2007.00013.x. PMID: 17627675; PMCID: PMC3771110.
2: Xi ZX, Newman AH, Gilbert JG, Pak AC, Peng XQ, Ashby CR Jr, Gitajn L, Gardner EL. The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats. Neuropsychopharmacology. 2006 Jul;31(7):1393-405. doi: 10.1038/sj.npp.1300912. Epub 2005 Oct 5. PMID: 16205781.
3: Yuan J, Chen X, Brodbeck R, Primus R, Braun J, Wasley JW, Thurkauf A. NGB 2904 and NGB 2849: two highly selective dopamine D3 receptor antagonists. Bioorg Med Chem Lett. 1998 Oct 6;8(19):2715-8. doi: 10.1016/s0960-894x(98)00469-7. PMID: 9873609.
4: Banasikowski TJ, Beninger RJ. Reduced expression of haloperidol conditioned catalepsy in rats by the dopamine D3 receptor antagonists nafadotride and NGB 2904. Eur Neuropsychopharmacol. 2012 Oct;22(10):761-8. doi: 10.1016/j.euroneuro.2012.02.004. Epub 2012 Mar 10. PMID: 22410316.
5: Spiller K, Xi ZX, Peng XQ, Newman AH, Ashby CR Jr, Heidbreder C, Gaál J, Gardner EL. The selective dopamine D3 receptor antagonists SB-277011A and NGB 2904 and the putative partial D3 receptor agonist BP-897 attenuate methamphetamine-enhanced brain stimulation reward in rats. Psychopharmacology (Berl). 2008 Mar;196(4):533-42. doi: 10.1007/s00213-007-0986-6. Epub 2007 Nov 6. PMID: 17985117; PMCID: PMC3713235.
6: Pritchard LM, Newman AH, McNamara RK, Logue AD, Taylor B, Welge JA, Xu M, Zhang J, Richtand NM. The dopamine D3 receptor antagonist NGB 2904 increases spontaneous and amphetamine-stimulated locomotion. Pharmacol Biochem Behav. 2007 Apr;86(4):718-26. doi: 10.1016/j.pbb.2007.02.019. Epub 2007 Mar 6. PMID: 17408730.
7: Gilbert JG, Newman AH, Gardner EL, Ashby CR Jr, Heidbreder CA, Pak AC, Peng XQ, Xi ZX. Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors. Synapse. 2005 Jul;57(1):17-28. doi: 10.1002/syn.20152. PMID: 15858839; PMCID: PMC3726034.
8: Martelle JL, Claytor R, Ross JT, Reboussin BA, Newman AH, Nader MA. Effects of two novel D3-selective compounds, NGB 2904 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxamide] and CJB 090 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide], on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther. 2007 May;321(2):573-82. doi: 10.1124/jpet.106.113571. Epub 2007 Feb 1. PMID: 17272677.
9: Thanos PK, Michaelides M, Ho CW, Wang GJ, Newman AH, Heidbreder CA, Ashby CR Jr, Gardner EL, Volkow ND. The effects of two highly selective dopamine D3 receptor antagonists (SB-277011A and NGB-2904) on food self-administration in a rodent model of obesity. Pharmacol Biochem Behav. 2008 Jun;89(4):499-507. doi: 10.1016/j.pbb.2008.02.003. Epub 2008 Feb 8. PMID: 18329700; PMCID: PMC2681081.
10: Li S, Song JH, Kim TI, Yoo WG, Won MH, Dai F, Hong SJ. Chemotactic migration of newly excysted juvenile Clonorchis sinensis is suppressed by neuro- antagonists. PLoS Negl Trop Dis. 2019 Aug 13;13(8):e0007573. doi: 10.1371/journal.pntd.0007573. PMID: 31408466; PMCID: PMC6691982.